Nature Communications (Oct 2018)

RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer

  • Hanna Yang,
  • Dongwan Hong,
  • Soo Young Cho,
  • Young Soo Park,
  • Woo Ri Ko,
  • Ju Hee Kim,
  • Hoon Hur,
  • Jongkeun Lee,
  • Su-Jin Kim,
  • Sun Young Kwon,
  • Jae-Hyuk Lee,
  • Do Youn Park,
  • Kyu Sang Song,
  • Heekyung Chang,
  • Min-Hee Ryu,
  • Kye Soo Cho,
  • Jeong Won Kang,
  • Myeong-Cherl Kook,
  • Nina Thiessen,
  • An He,
  • Andy Mungall,
  • Sang-Uk Han,
  • Hark Kyun Kim

DOI
https://doi.org/10.1038/s41467-018-06747-4
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 13

Abstract

Read online

Diffuse Gastric Cancer (DGC) is increasingly being considered separate to intestinal type gastric cancer; several fusions events have been reported as drivers of the disease but few of those have been subsequently validated. Here the authors perform RNA-seq on early-onset DGC patients who had not been treated with chemotherapy or radiation and identify a previously unknown fusion.